Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irbesartan and Hydrochlorothiazide Tablets

Approval Number

国药准字H20213739

Company国药集团国瑞药业有限公司

Registration Date

September 24, 2021

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪片

Dosage Form

片剂

Strength

每片含厄贝沙坦150mg，氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

September 24, 2021

Company Information

Applicant Company

Company Name国药集团国瑞药业有限公司

Company Address

安徽省淮南市经济技术开发区朝阳东路16号

Manufacturing Company

Company Name国药集团国瑞药业有限公司

Company Address

安徽省淮南市经济技术开发区朝阳东路16号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy